ArticleEuropean journal of nuclear medicine and molecular imaging2022

A clinical study of a CD44v6-targeted fluorescent agent for the detection of non-muscle invasive bladder cancer.

Wenting Shang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.